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ABSTRACT: It is shown here that controlled mixing of a
gelator, drug, solvent, and antisolvent in a microﬂuidic channel
leads to faster setting gels and more robust materials with
longer release proﬁles than the physical gels of the same
composition obtained using random mixing in solution. The
system is similar to a related gelator system we had studied
previously, but we were unable to apply the same gelling
procedure because of the instability of the colloid caused by
the small structural modiﬁcation (length of the alkyl chain in
the bis-imidazolium head group). This situation holds true for
the gels formed with varying compositions and under diﬀerent
conditions (gelator/drug ratio, solvent proportion, and ﬂow rates), with the most signiﬁcant diﬀerences being the improved gel
rheology and slower drug release rates. Very importantly, the gels (based on a previously unexplored system) have a higher water
content ratio (water/EtOH 4:1) than others in the family, making their medicinal application more attractive. The gels were
characterized by a variety of microscopy techniques, X-ray diﬀraction and infrared spectroscopy, and rheology. Salts of the
antiinﬂammatory drugs ibuprofen and indomethacin were successfully incorporated into the gels. The diﬀraction experiments
indicate that these composite gels with relatively short alkyl chains in the gelator component contrast to previous systems, in that
they exhibit structural order and the presence of crystalline areas of the drug molecule implying partial phase separation (even
though these drug crystallites are not discernible by microscopy). Furthermore, the release study with the gel incorporating
ibuprofenate showed promising results that indicate a possible drug delivery vehicle application for this and related systems.
■ INTRODUCTION
The control of nanostructure in soft matter systems is
important in a number of areas,1−4 among them in the
preparation of materials for controlled drug delivery.5−9 Gels
can be chemical (comprising a covalent network) or physical
(or supramolecular, comprising noncovalent bonds).10−13
Polymeric chemical gels comprise covalently bonded networks
of ﬁbers that cannot be redissolved, and the structures are
thermally irreversible, which make them limited where
relatively rapid degradation is preferred. Hence, physical
(macro)molecular gels, where noncovalent interactions lead
to gelation and are generally characterized by their structural
reversibility under thermal and mechanical stress, could be a
better choice for drug delivery applications.14,15 Supramolecular
gels can be formed at low temperature, with the majority of the
solvent component trapped between the entangled and
intertwined nanoﬁbrous networks that are often held together
by London dispersion forces between the alkyl chains of the
gelator.
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Gemini-imidazolium amphiphiles are one such kind of
supramolecular material16 existing as colloids17−19 and that
can form gels20 useful for drug delivery, where the cationic
nature of the head group provides a location for interaction
with drug molecules.21,22 Previously, we have explored the
gelation ability in bulk of gemini-imidazolium amphiphiles
related to compounds 1−3 (Figure 1),21,22 comprising two
imidazolium rings linked through a bis-methylenebenzene
spacer (either 1,3- or 1,4-substituted) and bearing n-octadecyl
chains. These gels were stable and capable of incorporating
anionic drugs as drug delivery systems mainly targeting topical
applications. However, in the course of our studies on related
compounds bearing shorter alkyl chains, we found that the bulk
gel formation (usually carried out in sample pots in our
experiments) sometimes led to a qualitatively inhomogeneous
material and the gel formationachieved by mixing aqueous
and ethanolic solutionscould be poorly reproducible. For this
reason, we sought a controlled mixing protocol that could
provide a reproducibly more homogeneous material. In doing
so, some intriguing eﬀects of mixing on supramolecular
composite gel formation have been discovered.
The mixing technique we used involved combining distinct
components under laminar ﬂow in a microﬂuidic chip, in which
small volumes of ﬂuids are combined in a channel with
micrometric dimensionsgenerally from tens to hundreds of
micrometers.23,24 Microﬂuidics has a growing range of
applications in various ﬁelds, from combinatorial materials
synthesis25,26 to biomedicine (drug delivery, separation, and
diagnostic devices).27−29 Among the many advantages of the
continuous preparation of materials using microﬂuidics30 are
the parallel and consecutive reactions in a single system, low
reagent consumption, and the highly controlled and steady
mixing, which can be useful for the preparation of nanoma-
terials.31 The mixing in the chips is characterized by a low
Reynolds number, and therefore, the ﬂow is laminar; mixing of
ﬂuids occurs only at the interface through diﬀusion with the
viscous force dominant and no lateral convection. In narrow
channels, the surface area to volume ratio is high and the heat
and mass transfer rate increases compared with other
conditions because of the steeper temperature and concen-
tration gradients.32,33 It has been demonstrated that the self-
assembly of amphiphiles can be controlled using a microﬂuidic
system to determine the ﬂow condition,31 but insomuch as we
are aware, excepting the fabrication of polymer microgels by
gelation in droplet microﬂuidics,34 there is no such experiment
on bulk gelling systems.
The initial hypothesis for our study was that inside the
microchannel, the dominant interfacial forces, enhanced heat
and mass diﬀusiontransfer, can be exploited to promote the
self-assembly process of the supramolecular gelators with the
drug molecule with diﬀerent ﬂow parameters to obtain stable
gels eﬃciently incorporating the drug. The basis for this
hypothesis is the observed inﬂuence of ﬂow on the formation of
nanoscale aggregates in solution.35 Our purpose is to show that
microﬂuidic systems can be used as a platform for supra-
molecular gel formation for materials for drug delivery
applications. Here, we demonstrate this proof of principle for
the gelator molecules 1−3 when combined with the sodium
salts of nonsteroidal antiinﬂammatory drugs ibuprofen and
indomethacin (Figure 1).
■ RESULTS AND DISCUSSION
The gelator molecules (prepared using methods described
elsewhere21,36,37) that contain between 14 and 16 carbon atoms
in their aliphatic chains were ﬁrst explored as gelators on their
own for mixtures of ethanol in water. The putative gel mixtures
were prepared by adding water (that acts as an antisolvent
here) to the gelator dissolved in ethanol, swirling the mixture
and leaving it undisturbed at room temperature for some time,
because gels do not form immediately. Under these conditions,
chaotic mixing takes place, and it is not possible to control
reproducibly the combination of the two liquids. To obtain the
optimum solvent mixture for gel formation, gelation experi-
ments with diﬀerent concentrations of the gelator and diﬀerent
proportions of ethanol and water were attempted. For the gels
with drug, diﬀerent aqueous concentrations of the sodium salt
of either ibuprofen or indomethacin were mixed with the
ethanolic solution of the gelator. Some of the diﬀerent
conditions tested for the gel formation incorporating these
drugs are shown in Table 1 (see Table S1 in the Supporting
Information for more details). Compound 1·2Br formed the
qualitatively less homogeneous (large ﬁbers were observed in
the only gel that formed) and less stable gel and was not taken
forward in the subsequent studies, whereas both 2·2Br and 3·
2Br formed more homogeneous and stable gels. The time for
Figure 1. Structures of the imidazolium-based gelators 1·2Br−3·2Br
and the sodium salts of ibuprofen and indomethacin.
Table 1. Selected Experimental Conditions and Results of
Bulk Mixing Gelation Experiments Using Gelators 1·2Br−3·
2Br at a Concentration of 10 mg/mLa
gelator
ethanol/water
ratio (v/v) drug
gelator/drug
ratio
(mol/mol)
gel
formation
gelation
time (h)
1·2Br 1:1 none no
3:7 none no
1:4 none yes 24
2·2Br 1:1 none no
3:7 none partial 24
1:4 none yes 5
1:4 Ibu 1:2 no
1:4 Ibu 1:1 yes 24
1:4 Ibu 2:1 yes 24
1:4 Ind 1:1 no
1:4 Ind 2:1 yes 120
3·2Br 1:1 none no
3:7 none partial 120
1:4 none yes 24
1:4 Ibu 1:2 no
1:4 Ibu 1:1 no
1:4 Ibu 2:1 yes 24
aIbuibuprofen (sodium salt); Indindomethacin (sodium salt).
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the gels to set properly was rather long (several hours to days,
see Table 1), an aspect that is improved dramatically by the
subsequent microﬂuidic preparation routes (see below).
The ethanol/water ratio is the dominant factor determining
gel formation, with the length of the alkyl chains playing a
lesser, though signiﬁcant, role in gelation ability across the
series studied here. None of the gelators are able to immobilize
a 1:1 volume mixture of the solvents, whereas all of them gel in
a 1:4 mixture of ethanol and water at a concentration of 10 mg/
mL. The analogous gelator with alkyl chains bearing 18 carbon
atoms21 does not form gels at this high water content at this
concentration (the maximum aqueous content is 2:3 ethanol/
water), although it does gel this mixture at a concentration of
only 5 mg/mL. In the present study, the higher ratio of water
possible for the gel formation probably arises from the fact that
the amphiphiles with shorter chains are less hydrophobic and
thus more soluble in the medium. On the other hand, the
shorter chains tend to lead to thicker ﬁbers, as seen visually
because of the much greater visible light scattering (see
photographs of a selection of the gels, Supporting Information,
Figure S1).
Another striking diﬀerence between the gels reported here
and the analogue with longer hydrocarbon chains is their ability
to have higher drug loadings while maintaining an apparently
homogeneous phase. Previously, only gels with a maximum
molar ratio of 4:1 (gelator/ibuprofen sodium salt) could be
obtained.21 Instead, for gelator 2·2Br, equimolar amounts of
gelator and ibuprofen (sodium salt) result in the formation of a
gel in a 1:4 ethanol/water mixture. For the sodium salt of
indomethacin in combination with 2·2Br, the equimolar
mixture does not form a gel, whereas the 2:1 mixture does.
The more favorable gel formation in the presence of the drug
molecules as a result of shortening of the alkyl chain in the
gelator (whereas the polar head group is identical) is an
interesting and potentially useful eﬀect. The gels prepared from
compounds 2·2Br and 3·2Br take longer to form than their
octadecyl homologue.21 Importantly, though, the higher
content of the drug in the gel achieved using these gelators
compared with previous ones represents a clear advantage
regarding drug loading.
During the preparation of these gels, occasionally, the
reproducibility of gel formation was not perfect, and it was clear
that occasionally inhomogeneous gels formed, sometimes with
a nongelated solvent present. To address this lack of
reproducibility, we turned to microﬂuidic mixing.
The microﬂuidic chips we employed comprised four
symmetric inlet channels that converge and continue as a
single channel, the microreactor, as seen in Figure 2. They were
obtained by the replica molding technique (soft lithography) of
a microfabricated mold using poly(dimethylsiloxane)
(PDMS).26,27 An outlet solvent proportion 20:80 ethanol/
water and a total gelator concentration 10 mg/mL were used in
all the microﬂuidic experiments. Diﬀerent ﬂow conditions were
tried to obtain a stable gel loaded with drug. The ﬂow rates for
every experiment are speciﬁed for Inlet 1, Inlet 2, Inlet 3, and
Inlet 4 in μL/min in Table 2.
Because ibuprofen sodium salt is soluble in both ethanol and
water, two experimental conﬁgurations were used. In
conﬁguration 1, the gelator was dissolved in ethanol and the
drug in the water streams (these conditions resemble the ones
used in the bulk mixing gelation experiments), whereas in
conﬁguration 2, both gelator and drug were dissolved in
ethanol. The inlet channels in the center (Inlets 2 and 3) were
connected to the ethanol solution containing gelator or
containing gelator and drug, and the outer inlet channels
(Inlets 1 and 4) were connected to water with drug or water,
respectively. A selection of experimental conditions is shown in
Table 2 (see the Supporting Information, Table S2, for more
information on gelation outcome and gelation time).
Visual comparison of the gels prepared in bulk solution with
those obtained using microﬂuidic mixing indicated that the
latter showed better quality; no excess solvent was ever visible,
the gels were more homogeneous (to the naked eye), had
better stability, and most importantly showed better drug-
loading capacity (up to a gelator/drug ratio of 1:1 for 2.2Br).
Additionally, the gelation process after microﬂuidic mixing is
faster when compared to the bulk gelation in all cases (on the
order of hours compared with days). This order of magnitude
increase in the speed of gelation is, for example, for the 2:1
2.2Br/indomethacin sample going from 120 h without
microﬂuidic mixing to only 2−3 h with microﬂuidic mixing.
This eﬀect is presumably a result of the faster self-assembly
arising from a more homogeneously distributed material and
nucleation sites in the mixture emerging from the microﬂuidic
channel. The nuclei grow homogeneously in three dimensions
to form an intertwined ﬁbrous network with apparently
uniform distribution that cannot be achieved by simple mixing
in bulk. Without any drug, the gels of 2·2Br and 3·2Br were
formed at ﬂow rates of 160 μL/min in the outer inlets (water)
and 40 μL/min in the middle inlets (gelator in ethanol) to
maintain the preferred 4:1 solvent proportion. When preparing
gels incorporating drug with conﬁguration 2 with a 2:1 gelator/
drug molar ratio, and at ﬂow rates 160/40/40/160, 3·2Br
formed a gel with ibuprofen (sodium salt) only, whereas 2·2Br
formed a gel with both ibuprofen (sodium salt) and
indomethacin (sodium salt). Increasing the molar ratio of
drug to 1:1 did not result in the formation of a gel with
ibuprofen (sodium salt). Therefore, diﬀerent ﬂow rates were
tried, and it was found that 2·2Br did form a gel with ibuprofen
(sodium salt) with a 1:1 molar ratio using conﬁguration 1 at a
ﬂow rate (80/20/20/80). Photographs of the diﬀerent
outcomes obtained by changing the ﬂow rates with a 1:1
molar ratio of 2·2Br and ibuprofen (sodium salt) using either
conﬁguration 1 or 2 are shown in Figure 3.
Figure 2. Photograph showing the inlets and outlet of the microﬂuidic
setup and the experimental conﬁgurations for the gelation experi-
ments.
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Forming the gel with 2·2Br and ibuprofen (sodium salt) at
1:1 molar ratio, using conﬁguration 1 and the initially tested
ﬂow rates (160/40/40/160) and (320/80/80/320), resulted in
a turbid white suspension (Figure 3A,B). Lower ﬂow rates were
then attempted: gel formation occurred at ﬂow rates (80/20/
20/80) (Figure 3C), and further reducing the ﬂow rates to half
(40/10/10/40) resulted in the partial formation of a gel that
had poor mechanical stability (Figure 3D). This evidence
suggests that the residence time inside the microchannel plays a
very important role in the evolution of the self-assembly of the
gelator in the presence of a drug molecule to form a stable gel
structure. The lack of stable gels at slower ﬂow rates is in no
doubt partly caused by the formation of agglomerates inside the
channels. Although this solid gets dispersed in the solvent
before collecting from the outlet, a nonhomogeneous partial gel
with a high amount of solvent not trapped inside is formed
because of the changing concentration of the gelator in the
eﬄuent from the chip. Using mixing conﬁguration 2, no gel
formation was observed. Instead, turbid solutions with a small
amount of deposits at the bottom were obtained (Figure 3E,F).
This observation suggests that a homogeneous mixture of
ibuprofen (sodium salt) and gelator in the ethanolic solution
does not favor the formation of long ﬁbers that lead to gelation
(vide infra).
The samples from the experiments where no gel was formed
under diﬀerent ﬂow rates were analyzed by dynamic light
scattering (DLS) (to determine the size distribution of the
particles present in the suspension) and scanning electron
microscopy (SEM) (to analyze the deposits obtained in the
outlet). DLS indicated that in all cases the particles had
diameters of around 1 μm (see Figure S3 in the Supporting
Information). The SEM images (Figure 4) show that the
output from the higher ﬂow rates (in conﬁguration 1) contains
phase-separated deposits that have a very heterogeneous ﬁbrous
Table 2. Microﬂuidic Mixing Gelation Experimentsa
ﬂow rates (μL/min)
gelator
gelator/drug ratio
(mol/mol) drug conﬁguration
Inlet 1
water
Inlet 2
ethanol
Inlet 3
ethanol
Inlet 4
water
gel
formation
gelation time
(h)
2·2Br none 160 40 40 160 yes 1
1:1 Ibu 1 320 80 80 320 no
1:1 Ibu 1 160 40 40 160 no
1:1 Ibu 1 80 20 20 80 yes 5−6
1:1 Ibu 1 40 10 10 40 partial 24
2:1 Ibu 2 160 40 40 160 yes 5
1:1 Ibu 2 160 40 40 160 no
1:1 Ibu 2 80 20 20 80 no
2:1 Ind 2 160 40 40 160 yes 2−3
3·2Br none 160 40 40 160 yes 18
1:2 Ibu 1 160 40 40 160 no
1:1 Ibu 1 160 40 40 160 no
2:1 Ibu 2 160 40 40 160 yes <24
aConﬁguration 1: Inlets 1 and 4 = water + drug, Inlets 2 and 3 = ethanol + gelator; conﬁguration 2: Inlets 1 and 4 = water, Inlets 2 and 3 = ethanol +
gelator + drug; Ibuibuprofen (sodium salt); Indindomethacin (sodium salt). Experiments gave a ﬁnal water/ethanol ratio of 80:20, so the ﬁnal
concentration of the gelator is 10 mg/mL.
Figure 3. Photographs of the outcomes from the attempted gel
formation with a 1:1 mixture of 2·2Br and ibuprofen (sodium salt)
conﬁguration 1 at ﬂow rates (A) 320:80:80:320, (B) 160:40:40:160,
(C) 80:20:20:80, and (D) 40:10:10:40 and conﬁguration 2 (E)
160:40:40:160 and (F) 80:20:20:80.
Figure 4. SEM images of output mixtures obtained with the
microﬂuidic system of 2·2Br and ibuprofen (sodium salt) (1:1)
from experiments with conﬁguration 1 (A) 320:80:80:320, (B)
160:40:40:160, and (C) 80:20:20:80 and conﬁguration 2 (D)
80:20:20:80. Images were taken with 4000× magniﬁcation; the scale
bar represents 20 μm in all images.
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structure with some particles that could come from the liquid
phase while drying (Figure 4A,B). The SEM images of the
partial gel that formed under lower ﬂow rates (half of the ﬂow
rates which formed a gel in conﬁguration 1) show that it
comprises ﬁbers with smaller width (when compared to the
case that formed a gel) and drug precipitate was also seen
(Figure 4C). Whereas in conﬁguration 2 with the same ﬂow
rates of conﬁguration 1 which formed a gel, also contains the
nonhomogeneous morphology with ﬁbers, particles that could
come from the liquid phase and crystals of drug due to phase
separation (Figure 4D).
Atomic force microscopy (AFM) and SEM were used to
determine the structural diﬀerences between the gels formed in
bulk or microﬂuidic mixing conditions (Figures 5 and 6). AFM
in the intermittent (“tapping”) mode of the xerogels of both 2·
2Br and 3·2Br shows that the ﬁbers of both colloids are not
single ﬁbers but co-parallel bundles of narrower ﬁbers that are
joined laterally. The gels formed by 2·2Br contain ﬁbers that
are much wider than those formed by 3·2Br, under both bulk
and microﬂuidic mixing conditions. For gelator 2·2Br, the
average width of the ﬁbers is similar in both cases,
approximately 450−650 nm, although the bulk gelation
experiment tends to produce ﬁber aggregates of lower order,
whereas those from microﬂuidic mixing can be several microns
wide and composed of several individual ﬁbers, as seen clearly
in the SEM images (Figure 5). For the gels formed by 3·2Br, a
more pronounced eﬀect is seen: in the bulk sample, the
polydisperse ﬁbers have widths of around 50−250 nm, whereas
from microﬂuidic mixing, more uniform 200−300 nm wide
ﬁbers are generated. Once again, a co-alignment of individual
ﬁbers to give tapes comprising multiple joined ﬁbers is
observed under microﬂuidic mixing conditions.
Comparison of the morphology of the gels formed with
drugs presents a trend (Figure 6) similar to that of the pure
gelators. The microﬂuidic mixing leads to ﬁbrous networks
observed in the xerogels by SEM that have much greater lateral
interﬁber connections, a feature especially prominent for the
samples incorporating drugs. All the gels are composed of ﬁbers
irrespective of the presence and type of drug, but the
morphology and dimensions of the ﬁbers diﬀer in each case:
the width of the ﬁbers of the gel without any drug is smaller
when compared to that of the gels with drugs both in bulk and
microﬂuidics gelation. This conﬁrms the inﬂuence of drug in
the assembly and consequently in the morphology of the ﬁbers.
It should also be noted that the gels of 2·2Br with drugs (both
ibuprofen sodium salt and indomethacin sodium salt) obtained
with the microﬂuidic system show much wider ﬁber bundles
(from a mean value of approximately 150 nm to 1 to 2 μm,
depending on the case, the visual appearance of the gels also
gives support to this observation). The ﬁbers of gels from 3·2Br
are smaller, fused with each other and with poorly deﬁned
edges (Supporting Information, Figure S4) when compared to
Figure 5. Representative AFM (left and colored) and SEM (right and grayscale) images of gels of 2·2Br and 3·2Br from gelation in solution and
microﬂuidic mixed systems. The scale bar is 1 μm in all images.
Figure 6. SEM images of the gels obtained with both bulk (A−D) and microﬂuidic mixing (E−H) obtained with 2·2Br (A,E), 2·2Br with ibuprofen
(sodium salt) 1:1 molar ratio (B,F) and 2:1 molar ratio (C,G) and with indomethacin (sodium salt) 2:1 molar ratio (D,H). Images were taken with
4000× magniﬁcation; scale bars represent 20 μm.
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gels from 2·2Br where the ﬁbers are relatively wider and more
distinct.
The diﬀerence in morphology of the gels is echoed in the
mechanical stability and viscoelastic properties of the materials.
Rheological studies of the gels of pure 2·2Br and 2·2Br
containing ibuprofen sodium salt prepared under both bulk and
microﬂuidic mixing (conﬁguration 1, ﬂow in inlets
80:20:20:80) conditions show important diﬀerences in the
materials. The use of microﬂuidic mixing increases both the
resistance to deformation, as seen in the G′ and G″ values
(storage and loss modulus) (Figure 7), and the resistance to
rupture, as seen in the critical stress values (Table 3). In the
case of the gel formed solely with 2·2Br (without drug), critical
stress is increased up to 24% when using a microﬂuidic mixing
platform as compared to the bulk process.
The mechanical properties of the gel are also aﬀected by the
incorporation of a drug. The gel incorporating ibuprofen
sodium salt prepared by the bulk process shows 82% less
resistance to rupture when compared to the gel without drug.
However, using microﬂuidic mixing, the gels with sodium
ibuprofenate are more than twice resistant to rupture, and four
times more ﬂexible, as seen in G′ values, when compared to the
bulk process gel with ibuprofen sodium salt (Figure 7). All
these data show that the supramolecular diﬀerences found in
gels as a result of using the microﬂuidic mixing signiﬁcantly
enhance their mechanical and viscoelastic properties.
The surrounding of the drug molecule in the gel formed with
an equimolar amount of 2·2Br and ibuprofen sodium salt using
the microﬂuidic system (at 80:20:20:80 ﬂow ratios) was
analyzed by infrared (IR) spectroscopy and powder X-ray
diﬀraction (PXRD) experiments. The IR spectra show, besides
the peaks that correspond to the gelator, the presence of a peak
at 1714 cm−1 that corresponds to the carboxylate group of
ibuprofen sodium salt (Supporting Information, Figure S5), but
no shifts in the signals from either compound corresponding to
the possible host−guest inclusion were witnessed, implying that
any contact between the gelator and the drug must be at the
interfaces between the materials. The PXRD (Figure 8) study
conﬁrmed this hypothesis. The diﬀractograms of the gel formed
by 2·2Br with ibuprofen sodium salt (1:1 molar ratio), from
both bulk and microﬂuidic mixing experiments, show a peak at
about 3.5 in 2θ that corresponds to the crystalline ibuprofen
sodium salt,21 suggesting that the drug crystallized in the gel
without incorporating into the bulk structure of the gel ﬁbers.
However, as presented above, drug crystals are not visible in the
images obtained by SEM (or by optical microscopy), and thus,
a layered structure must be present in the ﬁbers with areas of
gelator and drug, presumably held together by electrostatic
interactions at the interfaces between the materials. Interest-
ingly, the peak that corresponds to ibuprofen sodium salt is
more intense in the gel from microﬂuidics (Figure 8B), which
Figure 7. Stress sweep tests of pure 2·2Br gels (A,B) and the same
gelator with ibuprofen sodium salt (C,D) prepared by bulk mixing
(A,C) or microﬂuidics (B,D).
Table 3. Rheological Properties of Gels from 2·2Br and
Incorporating Ibuprofen Sodium Salt (Ibu)
drug mixing method critical stress (Pa) crossover (Pa)
none bulk 10 45.8
none microﬂuidic 12.4 36.8
Ibu bulk 1.76 8.2
Ibu microﬂuidic 4.18 19.2
Figure 8. Powder X-ray diﬀractograms of xerogels formed with 2·2Br,
without drug and with ibuprofen sodium (1:1 molar ratio) prepared
(A) in bulk solution and (B) using microﬂuidic at a ﬂow rate ratio of
80:20:20:80 in conﬁguration 1.
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suggests that the ﬁber growth occurs along this crystallographic
direction of the drug. The gelator has similar relative intensities
in diﬀraction peaks, which suggests that the ﬁber growth is
favored under both bulk and microﬂuidic mixing conditions.
These results concerning long-range order in the gels
contrast with the ones seen with gels prepared using the
analogous gelator containing 18 carbon atoms in the alkyl
chain, where no drug crystallinity could be observed by PXRD
(albeit it at a lower drug loading).21 Although the higher drug
loading used in these gels may contribute to this factor, the
morphology of the drug is clearly modiﬁed and the crystalline
areas are indistinguishable from those of the gelator.
The ability of the drug-loaded gels to release the
incorporated compound was studied in materials with the
highest ibuprofen sodium salt content. Both, the gel prepared
with mixing in the microﬂuidic platform (ﬂow rate ratio of
80:20:20:80 in conﬁguration 1) and the gel obtained with bulk
preparation, were studied for comparison purposes. The release
was performed in vitro using a Franz-cell system, with a
receptor phase with pH 7.4 all maintained at 37 °C to simulate
human physiological conditions. The amount of the released
drug was calculated as a percentage of the total amount of the
drug present in the gel. Three diﬀerent kinetic models that can
describe the drug release from hydrogels (ﬁrst-order release,
Peppas−Korsmeyer and Higuchi) were used to ﬁt the
experimental data obtained. The Akaike information criterion
(AIC) was calculated to determine which model presents the
best adjustment (see the Supporting Information, Table S3).
The release proﬁles for the two gels are shown in Figure 9.
The most important diﬀerence found between the gels is the
release kinetics. The gel prepared in bulk follows ﬁrst-order
release kinetics, whereas that obtained with the microﬂuidic
system follows a Higuchi model, which resembles a ﬁrst-order
model during the ﬁrst hours, but does not reach a plateau,
suggesting that the drug could keep releasing with time.
Regarding the speed of the drug release, the bulk prepared gel
shows a faster release, with a constant KD of 0.017 h
−1. The
maximum amount of ibuprofen salt that can be released is
around 55%, and after 40 h, half of this value is already reached.
The gel prepared using microﬂuidics, on the other hand, shows
a slower release proﬁle. The KD is 3.08 h
−1, and after 48 h only
20% of the total drug is released. The release of 50% of the total
amount of drug would take around 260 h. Even though the
initial release seems faster, afterward, it slows down. The release
is constant, but the amount being released is very small and the
time interval is very wide.
All these diﬀerences found in the drug release proﬁles
between microﬂuidics and bulk prepared gels could be
explained by the morphological and rheological diﬀerences
between them. With regard to the previous studies with
gelators with a similar structure, but with longer alkyl chains, it
was found that more than 75% of ibuprofen salt was released
under similar conditions, although loading of the drug was
much lower (gelator/drug ratio 4:1).21 In the present case, the
bulk gel can release up to 50%. It is sure that these gels are able
to load a much higher amount of the drug (gelator/drug ratio
1:1) when compared to the previously described ones, which
means that the amount of the drug released per weight of the
composite is approximately ﬁve times higher. Furthermore, the
eﬀect of microﬂuidic mixing produces a diﬀerent release proﬁle
to bulk mixing and therefore is a useful tool to employ in the
preparation of gel-derived release systems.
■ CONCLUSIONS
The gels described here show the dramatic eﬀect that the chain
length of the gelator can have on the incorporation of guest
drug compounds and their morphology and consequently on
their release characteristics. These eﬀects are true for samples
prepared in bulk solution mixing conditions as well as using a
microﬂuidic system to mix the two solution components of the
far-from-equilibrium system. In microﬂuidic mixing conditions,
the ﬂow rates and residence time inside the microchannel
greatly inﬂuence the gel formation. We show an order of
magnitude increase in the speed of gelation in certain cases, for
example, the 2:1 gelator/indomethacin sample gels in 120 h
without microﬂuidic mixing and only 2−3 h with microﬂuidic
mixing. The eﬀect of diﬀusive mixing taking place at the early
stages of assemblyas is the case for liposome systems38is
propagated into the formation of the gel, even in the presence
of drugs that are incorporated. These eﬀects may be of interest
for the preparation of other composite materials, such as gel−
nanoparticle materials,39 and for the use of this kind of mixing
in additive manufacturing applications of soft materials.40 The
gels formed under microﬂuidic mixing here were found to be
more stable, consistent, and with better drug incorporation
than the gels from bulk gelation, and the combination of gels
for vehicles and microﬂuidics for mixing are promising variables
in the search for materials for drug delivery.
■ EXPERIMENTAL SECTION
General Methods. The SEM images of the xerogels were
acquired by the electron microscopy service in the ICMAB-
CSIC on a Quanta FEI 200 FEG-ESEM system. The dry gels
on the carbon tape were coated with gold before imaging to
avoid the charging of the samples. All the images were taken at
15 kV, with a spot size of 3−4 and a working distance of ≈ 10
mm under high vacuum conditions. AFM images were recorded
by the scanning probe microscopy service at ICMAB-CSIC on
a PicoSPM system (molecular imaging). The intermittent
contact mode was used close to resonance frequencies of the
silicon cantilevers (nanosensors, FM type force constant 1.2−
3.5 N/m and tip diameter 5 nm) of around 60−70 kHz. All the
images were recorded under atmospheric conditions.
The IR spectra of dry gels were obtained with spectrometer
PerkinElmer Spectrum One FT-IR, energy range: 450−4000
cm−1 using the universal attenuated total reﬂectance accessory
(U-ATR).
Figure 9. Drug release proﬁles, at pH 7.4 and 37 °C, of ibuprofen
sodium salts from the gels of 2·2Br obtained by microﬂuidics and bulk
gelation processes.
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XRD measurements were performed with a Siemens D-5000
X-ray diﬀractometer. The source was a DRX ceramic tube (λ
Cu Kα = 1.540560 Å and λ Cu Kα 2 = 1.544390 Å) with a
voltage and current of 45 kV and 35 mA, respectively. The gel
was mounted on a glass slide and dried and was scanned from
2θ = 2.5 to 2θ = 75°.
DLS was performed using Zetasizer Nano ZS, Malvern
Instruments for the samples from microﬂuidics which formed
turbid solution at room temperature. Only the solution was
taken in the cuvette.
The rheological characterization was performed at 32 °C
using a HAAKE RheoStress 1 rheometer (Thermo Fisher
Scientiﬁc, Karlsruhe, Germany) connected to a Thermo Haake
Phoenix II + Haake C25P temperature controller. The
rheological studies were carried out on freshly prepared
samples in the native state. The oscillatory test was conducted
with a plate−plate setup (Haake PP60 Ti, 60 mm diameter, 1
mm gap between plates), by performing oscillatory stress
sweeps between 0.1 and 100 Pa at 1 Hz, to determine the
resistance to deformation, related to storage modulus (G′) and
loss modulus (G″), and the phase shift (δ). Both the
viscoelastic moduli are deﬁned as follows: G′ = τ0/γ0 cos δ
and G″ = τ0/γ0 sin δ (where τ0 and γ0 are the amplitudes of
stress and strain).
Microfabrication of Microﬂuidic Chips. The micro-
channels were formed by transferring the complementary
structure of a silicon master (fabricated by the standard
photolithography of SU-8 epoxy resist on the silicon substrate)
to PDMS and bonding the latter to glass. The length, width,
and height of the microreactor in the chip are 10 mm, 250 μm,
and 50 μm, respectively. Fabrication of the PDMS chips was
carried out in the Nanoquim platform class 10000 (ISO7) clean
room facility (ICMAB-CSIC scientiﬁc and technical services)
under controlled room conditions (T = 21 °C, ΔP = 20 mbar
and RH ≤ 45%). PDMS (20 g) and curing agent (1.8 g) were
taken and mixed well. The mixture was degassed with vacuum
for 30 min. Then the mixture was poured without any bubbles
onto a mold which was placed on the silicon master containing
the structure (complementary structure of microchannels). It
was then cured in an oven at 150 °C for 10 min. PDMS got
solidiﬁed, and holes were made at the ends of the inlet and
outlet channels for the external connection. The surface of
PDMS which contains the structure (channels) and a side of a
glass slide were exposed to nitrogen plasma for 1 min and 30 s.
PDMS was placed on the glass slide (with the sides exposed to
plasma), pressed well, and kept on a hot plate at 75 °C
overnight for the bonding to occur.
Bulk Gelation. For all bulk gelation experiments without
any drug, the gelator was dissolved in ethanol, and water was
added (v/v ratio depends on the experiment, see Table 1) and
mixed well. For the gel with ibuprofen (sodium salt), the drug
was dissolved in water and added to the ethanolic solution of
the gelator and mixed well. For the gels with indomethacin
(sodium salt), both gelator and drug were dissolved in ethanol
and water was added to the solution and mixed well by stirring
by hand. All the experiments were done at room temperature
and were kept undisturbed after mixing until the formation of
gels.
Mixing Using a Microﬂuidic System for Gelation.
Experiments using the microﬂuidic chips described above were
carried out by taking the solutions in the syringe (volume and
concentration depend on the need of the experiment) that were
connected to the holes of the inlet channels of the PDMS chip
through a tube of 1 mm diameter. The ﬂow rates (see Table 2)
were controlled by neMESYS low-pressure syringe pumps,
Cetoni Automation and Microsystems GmbH, Germany. The
output of the experiments was collected with a small outlet tube
(1 mm in diameter) connected to the hole in the outlet
channel. The neMESYS user interface software was used to
control the syringe pumps.
Drug Release Experiments. For the release study, two
gels were chosen: the gel obtained using the microﬂuidic
system (conﬁguration 1 ﬂow rate ratios 80:20:20:80), and the
corresponding gel obtained in bulk conditions with an ethanol/
water proportion of 20:80 and a gelator/drug molar ratio of
1:1. The release of the drugs from the gels was performed in a
Microette transdermal diﬀusion system (Microette plus-
Hanson Research) with vertically assembled Franz-type
diﬀusion cells (crown glass). Dialysis membranes (Cellu Sep
T3 dialysis membrane, MWCO 12 000−14 000 Da, MFPI,
USA), previously hydrated in water/methanol 1:1, were placed
in the Franz-type diﬀusion cells. Known weights of gel were
placed into the donor compartment onto the dialysis
membranes. The dialysis membrane and the donor container
were put onto the glass receptor chamber, and the assembly
was ﬁxed with a joint. The receptor chamber contained
phosphate-buﬀered saline 100 mM pH 7.4, which complies
with the SINK conditions. The Franz-type cells were connected
to a controlled temperature system, with a heating bath set to
37 °C. Samples were taken at given time intervals, and the
sample taken was replaced by an equal volume of the receptor
solution.
Drug determination in samples was done by high-perform-
ance liquid chromatography in a Waters LC module I, in a
Waters Spherisorb 5 μm ODS-2 (4.6 mm × 150 mm) column.
The mobile phase consisted of acetonitrile/water (acidiﬁed to
pH 3 with phosphoric acid) 65:35, with a ﬂow rate of 1.5 mL
min−1, and the detection wavelength was set to 220 nm. The
data were collected using Millennium32 version 4.0.0 software
from Waters Corp. All data were calculated as the average ±
standard deviation of three replicates. A nonlinear least-squares
regression was performed using the WinNonLin software
(WinNonlin Professional edition version 3.3, Pharsight Corp.,
USA), and the model parameters were calculated. Modelistic
parameters were statistically compared by using Statgraphics
software version 5.1.
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García, L. In situ template synthesis of gold nanoparticles using a bis-
imidazolium amphiphile-based hydrogel. J. Colloid Interface Sci. 2015,
446, 53−58.
(40) Sommer, M. R.; Alison, L.; Minas, C.; Tervoort, E.; Rühs, P. A.;
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